Dr. Liebson is Professor of Medicine and Preventive Medicine at Rush Medical College and holds the McMullan-Eybel Chair of Excellence in Clinical Cardiology. He attended Columbia University and received his MD degree at the State University of NY Downstate Medical Center. He had his residency at Lenox Hill Hospital and the Manhattan VA Hospital in NY City and his cardiology fellowship at Bellevue Hospital 2nd (Cornell) Medical Division and the NY Hospital Cornell Medical Center. He was Assistant Professor at NY Hospital-Cornell where his research included studies in the Myocardial Infarction research Unit and the use of radioisotopes to assess infarct size in animal models. Most of his academic career has been at Rush University Medical Center where he has held the positions of Director of the Medical Intensive Care Unit, Electrocardiography Unit, Echocardiography Unit, and Acting Director of the Cardiology Section.
His research has included studies of the effects of antihypertensive agents on left ventricular hypertrophy and he participated in a number of NIH sponsored trials including the Treatment of Mild Hypertension Study and the Cardiac Arrhythmia Suppression Trial.
He has been a reviewer for Circulation, the Journal of the American College of Cardiology, American Heart Journal and Annals of Internal medicine. He is or has been a Fellow of the American College of Cardiology, American Heart Association including the C clinical Councils of High Blood pressure Research and Epidemiology. He is a past president of the American Society of Preventive Cardiology and the Chicago Society of Echocardiography.
Among his numerous awards was the NIH sponsored Preventive Cardiology Academic Award and the International Academy of Cardiology: Jan J. Kellermann Memorial Award for distinguished contribution to the field of cardiovascular disease prevention-14th World Congress of Cardiology. He has participated in NIH site reviews.
He has contributed a total of 455 manuscripts, abstracts, editorials, books and book chapters. He is currently on the writing group of the ACC/AHA sponsored 2013 guidelines for management of unstable angina/non–ST-elevated myocardial infarction.